These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12670444)
1. Platelet-derived growth factor up-regulates the expression of transcription factors NF-E2, GATA-1 and c-Fos in megakaryocytic cell lines. Chui CM; Li K; Yang M; Chuen CK; Fok TF; Li CK; Yuen PM Cytokine; 2003 Jan; 21(2):51-64. PubMed ID: 12670444 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells. Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463 [TBL] [Abstract][Full Text] [Related]
3. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin. Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines. Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954 [TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823 [TBL] [Abstract][Full Text] [Related]
6. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677 [TBL] [Abstract][Full Text] [Related]
7. The role of cytokines and transcription factors in megakaryocytopoiesis. Yang M; Li K Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):580-5. PubMed ID: 12513728 [TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Yang M; Li K; Chui CM; Yuen PM; Chan PK; Chuen CK; Li CK; Fok TF Br J Haematol; 2000 Oct; 111(1):371-80. PubMed ID: 11091227 [TBL] [Abstract][Full Text] [Related]
9. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Vyas P; Ault K; Jackson CW; Orkin SH; Shivdasani RA Blood; 1999 May; 93(9):2867-75. PubMed ID: 10216081 [TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis. Catani L; Vianelli N; Amabile M; Pattacini L; Valdrè L; Fagioli ME; Poli M; Gugliotta L; Moi P; Marini MG; Martinelli G; Tura S; Baccarani M Leukemia; 2002 Sep; 16(9):1773-81. PubMed ID: 12200693 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the two alternative promoters of human p45 NF-E2 gene. Toki T; Arai K; Terui K; Komatsu N; Yokoyama M; Katsuoka F; Yamamoto M; Ito E Exp Hematol; 2000 Oct; 28(10):1113-9. PubMed ID: 11027829 [TBL] [Abstract][Full Text] [Related]
13. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198 [TBL] [Abstract][Full Text] [Related]
14. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells. Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115 [TBL] [Abstract][Full Text] [Related]
15. GATA transcription factors associate with a novel class of nuclear bodies in erythroblasts and megakaryocytes. Elefanty AG; Antoniou M; Custodio N; Carmo-Fonseca M; Grosveld FG EMBO J; 1996 Jan; 15(2):319-33. PubMed ID: 8617207 [TBL] [Abstract][Full Text] [Related]
16. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206 [TBL] [Abstract][Full Text] [Related]
17. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. Ishiko E; Matsumura I; Ezoe S; Gale K; Ishiko J; Satoh Y; Tanaka H; Shibayama H; Mizuki M; Era T; Enver T; Kanakura Y J Biol Chem; 2005 Feb; 280(6):4929-39. PubMed ID: 15563463 [TBL] [Abstract][Full Text] [Related]
18. Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation. Vitrat N; Letestu R; Massé A; Lazar V; Vainchenker W; Debili N Thromb Haemost; 2000 May; 83(5):759-68. PubMed ID: 10823275 [TBL] [Abstract][Full Text] [Related]
19. Effects of chebulinic acid on differentiation of human leukemia K562 cells. Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215 [TBL] [Abstract][Full Text] [Related]